Website profile

Quiver Quantitative

Quiver Quantitative is a leading provider of stock trading data for retail investors The next generation of investment research Quiver Quantitative

  • 1,367articles · 30d
  • 1+ day agolatest article
  • Aug 14, 2026earliest in window
  • 0%with images
  • 302avg words
articles per day
Categories
  • News 828
  • Economy, Business & Finance 778
  • Finance & Business 651
  • Politics 646
  • Politics2 558
  • Finance 231
  • Business & Industrial 90
  • Health & Wellness 90

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Quiver Quantitative
quiverquant.com > news > Press+Release%3A+Sean+Casten+and+Elmhurst+University+Announce+Federal+Funding+for+Health+Research+Technology

Press Release: Sean Casten and Elmhurst University Announce Federal Funding for Health Research Technology | Stock News

2+ day, 17+ hour ago   (362+ words) Casten and Elmhurst University announced $950,000 in federal funding for health sciences research and simulation equipment. Funding announced at Elmhurst University: U.S. Rep. Sean Casten and Elmhurst University said the school will receive $950,000 in federal funding for instructional, simulation, and research equipment…...

quiverquant.com
quiverquant.com > news > Press+Release%3A+Shri+Thanedar+Leads+Bipartisan+Resolution+for+National+Suicide+Prevention+Month

Press Release: Shri Thanedar Leads Bipartisan Resolution for National Suicide Prevention Month | Stock News

2+ day, 15+ hour ago   (375+ words) Bipartisan resolution designates September as Suicide Prevention Month, promoting mental health awareness and access to care. Lawmakers introduce suicide-prevention resolution: Rep. Shri Thanedar, joined by Reps. Wesley Bell and Mike Lawler, introduced a bipartisan resolution to recognize September as National…...

Quiver Quantitative
quiverquant.com > news > Press+Release%3A+Diana+Harshbarger+Introduces+Bill+to+Update+FDA+Drug+Preclusion+Rules

Press Release: Diana Harshbarger Introduces Bill to Update FDA Drug Preclusion Rules | Stock News

2+ day, 17+ hour ago   (309+ words) Harshbarger proposes FDA reforms to clarify drug preclusion rules and protect dietary supplement access. Harshbarger proposal: Rep. Diana Harshbarger said she introduced the Dietary Supplement Innovation Act, which would update FDA “drug preclusion” rules and set clearer standards for when…...

Quiver Quantitative
quiverquant.com > news > Press+Release%3A+Aderholt+Announces+Rural+Health+Funding+for+Lakeland+Community+Hospital

Press Release: Aderholt Announces Rural Health Funding for Lakeland Community Hospital | Stock News

2+ day, 19+ hour ago   (373+ words) Rural health event in Haleyville: Congressman Robert Aderholt said he joined HRSA Administrator Tom Engels at Lakeland Community Hospital for a Rural Healthcare Champions Recognition Event. The release says the announcement was made in Aderholt’s hometown and focused on rural…...

Quiver Quantitative
quiverquant.com > news > Vistagen+to+Present+Phase+3+Fasedienol+Data+in+Severe+Social+Anxiety+Disorder+at+Psych+Congress%0A

Vistagen to Present Phase 3 Fasedienol Data in Severe Social Anxiety Disorder at Psych Congress | VTGN Stock News

3+ day, 59+ min ago   (108+ words) Vistagen will present positive Phase 3 data for fasedienol nasal spray in social anxiety disorder at Psych Congress. Fasedienol nasal spray is a Phase 3 product candidate developed by Vistagen for the acute treatment of social anxiety disorder. Vistagen will present data…...

Quiver Quantitative
quiverquant.com > news > Disc+Medicine+Reports+Positive+Initial+RESTORE-PV+Results+for+DISC-3405+in+Polycythemia+Vera

Disc Medicine Reports Positive Initial RESTORE-PV Results for DISC-3405 in Polycythemia Vera | IRON Stock News

3+ day, 14+ hour ago   (249+ words) Initial results from RESTORE-PV show DISC-3405 improves symptoms in polycythemia vera by increasing hepcidin and reducing phlebotomy needs. The RESTORE-PV trial showed that DISC-3405 increased hepcidin, lowered serum iron, and reduced phlebotomy in PV patients. DISC-3405 is a monoclonal antibody…...

quiverquant.com
quiverquant.com > news > Press+Release%3A+Rep.+Hillary+Scholten+Introduces+Two+Health+Care+Bills+on+Prescription+Drug+Costs+and+Hospital+Access

Press Release: Rep. Hillary Scholten Introduces Two Health Care Bills on Prescription Drug Costs and Hospital Access | Stock News

3+ day, 19+ hour ago   (410+ words) 50% off your first year of any Quiver subscription Scholten introduced bills to cap prescription costs and protect hospitals’ drug discount access amid Medicaid cuts. Scholten announces two health care bills: Rep. Hillary Scholten said she introduced the “Fair Prescription Pricing…...

Quiver Quantitative
quiverquant.com > news > Press+Release%3A+Bresnahan+Announces+%24475%2C175+Grant+for+Luzerne+County+Community+College+Nursing+Program

Press Release: Bresnahan Announces $475,175 Grant for Luzerne County Community College Nursing Program | Stock News

3+ day, 21+ hour ago   (397+ words) 50% off your first year of any Quiver subscription Representative Bresnahan announced a $475,175 federal grant to expand LCCC’s nursing program and healthcare workforce training. Grant announced for nursing program: Rep. Rob Bresnahan said Luzerne County Community College has received a $475,175 federal…...

quiverquant.com
quiverquant.com > news > Context+Therapeutics+Doses+First+Patient+in+Phase+1+Trial+of+CT-202+for+Solid+Tumors

Context Therapeutics Doses First Patient in Phase 1 Trial of CT-202 for Solid Tumors | CNTX Stock News

4+ day, 2+ hour ago   (312+ words) 50% off your first year of any Quiver subscription Context Therapeutics initiates a Phase 1 trial for CT-202, targeting Nectin-4 in solid tumors. Initial data expected in 2027. CT-202 is a Nectin-4 x CD3 T cell engaging bispecific antibody being tested as a monotherapy…...

Quiver Quantitative
quiverquant.com > news > MannKind+and+Rose+Pharma+Enter+Worldwide+Collaboration+to+Develop+Inhaled+ROSE-010+Technosphere+for+Weight+Management

MannKind and Rose Pharma Enter Worldwide Collaboration to Develop Inhaled ROSE-010 Technosphere for Weight Management | MNKD Stock News

4+ day, 3+ hour ago   (312+ words) 50% off your first year of any Quiver subscription MannKind and Rose Pharma collaborate to develop ROSE-010, an inhaled GLP-1 for weight management and potential IBS treatment. MannKind will provide pharmaceutical development and manufacturing support through the completion of a Phase…...